Copyright
©2011 Baishideng Publishing Group Co.
World J Diabetes. Nov 15, 2011; 2(11): 204-210
Published online Nov 15, 2011. doi: 10.4239/wjd.v2.i11.204
Published online Nov 15, 2011. doi: 10.4239/wjd.v2.i11.204
Animal Groups | Cholestrol (mg/dL) | Triglyceride (mg/dL) | HDL (mg/dL) | LDL (mg/dL) |
Control | 69.41 ± 7.02 | 70.66 ± 6.66 | 41.28 ± 2.27 | 36.37 ± 1.91 |
Diabetic control | 110.20 ± 5.09b | 166.09 ± 8.53c | 30.14 ± 1.83b | 51.42 ± 2.80b |
Cerium oxide | 109.98 ± 5.53c | 166.05 ± 10.03c,f | 29.00 ± 1.95c,f | 60.14 ± 1.62c,g |
Nanocerium oxide | 107.02 ± 1.48b | 123.37 ± 8.72b,d | 38.42 ± 1.46d | 49.00 ± 2.80a |
Sodium selenite | 102.22 ± 6.77b | 123.25 ± 6.43b,d | 38.00 ± 1.43d | 40.66 ± 2.66d |
Nanocerium oxide + Sodium selenite | 106.15 ± 5.79b | 113.10 ± 8.17a,e | 39.60 ± 2.13d | 39.14 ± 2.79d |
- Citation: Pourkhalili N, Hosseini A, Nili-Ahmadabadi A, Hassani S, Pakzad M, Baeeri M, Mohammadirad A, Abdollahi M. Biochemical and cellular evidence of the benefit of a combination of cerium oxide nanoparticles and selenium to diabetic rats. World J Diabetes 2011; 2(11): 204-210
- URL: https://www.wjgnet.com/1948-9358/full/v2/i11/204.htm
- DOI: https://dx.doi.org/10.4239/wjd.v2.i11.204